Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EVOlocumab in Stable Heart Failure With Reduced Ejection Fraction of Ischemic Etiology: EVO-HF Pilot

NCT03791593 is registered in ClinicalTrials.gov with Fundació Institut Germans Trias i Pujol as lead sponsor.

NCT NCT03791593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03791593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EVOlocumab in Stable Heart Failure With Reduced Ejection Fraction of Ischemic Etiology: EVO-HF Pilot
Lead sponsor
Fundació Institut Germans Trias i Pujol
Phase
Phase 2
Overall status
Completed
Start date
December 3, 2018
Completion date
July 20, 2022
Enrollment
46 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with reduced ejection fraction